Literature DB >> 31320458

Increase in circulating ACE-positive endothelial microparticles during acute lung injury.

Yusuke Takei1, Mitsuhiro Yamada2, Koji Saito3, Yoshinobu Kameyama3, Hisatoshi Sugiura2, Tomonori Makiguchi2, Naoya Fujino2, Akira Koarai2, Hiroaki Toyama1, Kazutomo Saito1, Yutaka Ejima1, Yu Kawazoe4, Daisuke Kudo4, Shigeki Kushimoto4, Masanori Yamauchi1, Masakazu Ichinose2.   

Abstract

Circulating endothelial microparticles (EMPs) are considered to be markers of endothelial injury, and lung microvascular endothelial cells express higher levels of angiotensin-converting enzyme (ACE). The aim of this study is to examine whether the number of ACE+ microvascular EMPs could be a prognostic marker for the development of acute respiratory distress syndrome (ARDS) in septic patients.The numbers of EMPs and ACE+ EMPs in the culture supernatant from human microvascular endothelial cells, as well as in the blood of mouse lung injury models and septic patients (n=82), were examined using flow cytometry.ACE+ EMPs in the culture supernatant from pulmonary microvascular endothelial cells increased after exposure to an inflammatory stimulus. In the mouse lung injury models, the circulating ACE+ EMPs and ACE+ EMP/EMP ratio were higher than in the controls (p<0.001). The ACE+ EMP/EMP ratio was correlated with the wet/dry lung ratio (rs=0.775, p<0.001). The circulating ACE+ EMPs and ACE+ EMP/EMP ratio on admission were significantly increased in septic patients who developed ARDS compared with septic patients who did not (p<0.001).Therefore, circulating ACE+ EMPs may be a prognostic marker for the development of ARDS in the septic patients.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 31320458     DOI: 10.1183/13993003.01188-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients.

Authors:  Alejandro García-Núñez; Gema Jiménez-Gómez; Antonio Hidalgo-Molina; Juan Antonio Córdoba-Doña; Antonio León-Jiménez; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

2.  Size Distribution of Microparticles: A New Parameter to Predict Acute Lung Injury After Cardiac Surgery With Cardiopulmonary Bypass.

Authors:  Hao-Xiang Yuan; Kai-Feng Liang; Chao Chen; Yu-Quan Li; Xiao-Jun Liu; Ya-Ting Chen; Yu-Peng Jian; Jia-Sheng Liu; Ying-Qi Xu; Zhi-Jun Ou; Yan Li; Jing-Song Ou
Journal:  Front Cardiovasc Med       Date:  2022-04-29

3.  Lymphatic and Blood Endothelial Extracellular Vesicles: A Story Yet to Be Written.

Authors:  Johanna Trisko; Johanna Fleck; Silvio Kau; Johannes Oesterreicher; Wolfgang Holnthoner
Journal:  Life (Basel)       Date:  2022-04-28

Review 4.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590

5.  Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence.

Authors:  Narci Teoh; Geoff Farrell
Journal:  J Clin Transl Res       Date:  2020-04-18

Review 6.  Endothelial Damage in Acute Respiratory Distress Syndrome.

Authors:  Alice G Vassiliou; Anastasia Kotanidou; Ioanna Dimopoulou; Stylianos E Orfanos
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

7.  Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation.

Authors:  Ayumi Mitsune; Mitsuhiro Yamada; Naoya Fujino; Tadahisa Numakura; Tomohiro Ichikawa; Ayumi Suzuki; Shuichiro Matsumoto; Yoshiya Mitsuhashi; Koji Itakura; Tomonori Makiguchi; Akira Koarai; Tsutomu Tamada; Shota Endo; Toshiyuki Takai; Yoshinori Okada; Satoshi Suzuki; Masakazu Ichinose; Hisatoshi Sugiura
Journal:  Respir Res       Date:  2021-08-23

8.  Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.

Authors:  Hassan A Hamali; Muhammad Saboor; Gasim Dobie; Aymen M Madkhali; Mohammad S Akhter; Ali Hakamy; Hesham M Al-Mekhlafi; Denise E Jackson; Yahya H Matari; Abdullah A Mobarki
Journal:  Infect Drug Resist       Date:  2022-04-29       Impact factor: 4.177

9.  Microparticles in COVID-19 as a link between lung injury extension and thrombosis.

Authors:  Olivier Morel; Benjamin Marchandot; Laurence Jesel; Laurent Sattler; Antonin Trimaille; Anais Curtiaud; Mickael Ohana; Samira Fafi-Kremer; Valerie Schini-Kerth; Lelia Grunebaum; Jean-Marie Freyssinet
Journal:  ERJ Open Res       Date:  2021-06-21

Review 10.  Targeting vascular inflammation through emerging methods and drug carriers.

Authors:  Jia Nong; Patrick M Glassman; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2022-03-07       Impact factor: 17.873

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.